Neuroprotective effect of erythropoietin on nandrolone decanoate-induced brain injury in rats

Neuroscience Letters

Volumn 533, Issue 1, 2013, Pages 28-33

  Tugyan, Kazim ^a   Ozbal, Seda ^a   Cilaker, Serap ^a   Kiray, Muge ^a   Pekcetin, Cetin ^a   Ergur, Bekir Ugur ^a   Kumral, Abdullah ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Brain; Erythropoietin; Hippocampus; Nandrolone decanoate; Rat

Indexed keywords

CASPASE 3; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NANDROLONE DECANOATE; RECOMBINANT ERYTHROPOIETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INJURY; BRAIN NERVE CELL; CELL COUNT; CELL DENSITY; CELL LEVEL; CONTROLLED STUDY; DENTATE GYRUS; DRUG EFFECT; DRUG MEGADOSE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; LOW DRUG DOSE; MALE; NEUROPROTECTION; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PARIETAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ANABOLIC AGENTS; ANIMALS; APOPTOSIS; BRAIN; BRAIN CHEMISTRY; BRAIN DISEASES; CELL COUNT; ERYTHROPOIETIN; HIPPOCAMPUS; MALE; NANDROLONE; NEURONS; NEUROPROTECTIVE AGENTS; PARIETAL LOBE; PREFRONTAL CORTEX; RATS; RATS, WISTAR;

EID: 84871672606     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.10.004     Document Type: Article

References (29)

1. van Amsterdam J., Opperhuizen A., Hartgens F. Adverse health effects of anabolic-androgenic steroids. Regulatory Toxicology and Pharmacology 2010, 57:117-123.
2. Brines M.L., Ghezzi P., Keenan S., Agnello D., Lanerolle N.C., Cerami C., Itri L.M., Cerami A. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proceedings of the National Academy of Science 2000, 97:10526-10531.
3. Calapai G., Marciano M.C., Corica F., Allegra A., Parisi A., Frisina N., Caputi A.P., Buemi M. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. European Journal of Pharmacology 2000, 401:349-356.
4. Carrillo M.C., Kanai S., Nokubo M., Kitani K. (-)Deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats. Life Sciences 1991, 48:517-521.
5. Digicaylioglu M., Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 2001, 412:641-647.
6. Hemmersbach P., Große J. Nandrolone: a multi-faceted doping agent. Handbook of Experimental Pharmacology 2010, 195:127-154.
7. Ishak K.G., Zimmerman H.J. Hepatotoxic effects of the anabolic/androgenic steroids. Seminars in Liver Disease 1987, 7:230-236.
8. Junk A.K., Mammis A., Savitz S.I., Singh M., Roth S., Malhotra S., Rosenbaum P.S., Cerami A., Brines M., Rosenbaum D.M. Erythropoietin administration protects retinal neurons from acute ischemia reperfusion injury. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:10659-10664.
9. Kadota T., Shingo T., Yasuhara T., Tajiri N., Kondo A., Morimoto T., Yuan W.J., Wang F., Baba T., Tokunaga K., Miyoshi Y., Date I. Continuous intraventricular infusion of erythropoietin exerts neuroprotective/rescue effects upon Parkinson's disease model of rats with enhanced neurogenesis. Brain Research 2009, 1254:120-127.
10. Koshimura K., Murakami Y., Sohmiya M., Tanaka J., Kato Y. Effects of erythropoietin on neuronal activity. Journal of Neurochemistry 1999, 72:2565-2572.
11. Kumral A., Genc S., Ozer E., Yilmaz O., Gokmen N., Koroglu T.F., Duman N., Genc K., Ozkan H. Erythropoietin downregulates bax and DP5 proapoptotic gene expression in neonatal hypoxic-ischemic brain injury. Biology of the Neonate 2006, 89:205-210.
12. Kumral A., Gonenc S., Acikgoz O., Sonmez A., Genc K., Yilmaz O., Gokmen N., Duman N., Ozkan H. Erythropoietin increases glutathione peroxidase enzyme activity and decreases lipid peroxidation levels in hypoxic-ischemic brain injury in neonatal rats. Biologia Neonatorum 2005, 87:15-18.
13. Lippi G., Franchini M., Banfi G. Biochemistry and physiology of anabolic androgenic steroids doping. Mini Reviews in Medicinal Chemistry 2011, 11:362-373.
14. Mammis A., McIntoch T.K., Maniker A.H. Erythropoietin as a neuroprotective agent in traumatic brain injury. Review. Surgical Neurology 2009, 71:527-531.
15. Naraghi M.A., Abolhasani F., Kashani I., Anarkooli I.J., Hemadi M., Azami A., Barbarestani M., Aitken R.J., Shokri S. The effects of swimming exercise and supraphysiological doses of nandrolone decanoate on the testis in adult male rats: a transmission electron microscope study. Folia Morphologica 2010, 69:138-146.
16. Niarz M., Sonnweber T., Schroll A., Theurl I., Weiss G. The pleiotropic effects of erythropoietin in infection and inflammation. Microbes and Infection 2012, 14:238-246.
17. Noguchi C.T., Asavaritikrai P., Teng R., Jia Y. Role of erythropoietin in the brain. Critical Reviews in Oncology/Hematology 2007, 64:159-171.
18. Oberlander J.G., Porter D.M., Penatti C.A.A., Henderson L.P. Anabolic androgenic steroid abuse: multiple mechanisms of regulation of GABAergic synapses in neuroendocrine control regions of the rodent forebrain. Journal of Neuroendocrinology 2012, 24:202-214.
19. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2002, Academic Press, New York.
20. Pillai A., Dhandapani K.M., Pillai B.A., Terry A.V., Mahadik S.P. Erythropoietin prevents haloperidol treatment-induced neuronal apoptosis through regulation of BDNF. Neuropsychopharmacology 2008, 33:1942-1951.
21. Rees S., Harding R., Walker D. The biological basis of injury and neuroprotection in the fetal and neonatal brain. International Journal of Developmental Neuroscience 2011, 29:551-563.
22. Saitoh T., Morimoto K., Kumagai T., Tsuboi I., Aikawa S., Horie T. Comparison of erythropoietic response to androgen in young and old senescence accelerated mice. Mechanisms of Ageing and Development 1999, 109:125-139.
23. Shahidi N.T. A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids. Clinical Therapeutics 2001, 23:1355-1390.
24. Shokri S., Aitken R.J., Abdolvahhabi M., Abolhasani F., Ghasemi F.M., Kashani I., Ejtemaeimehr S., Ahmadian S., Minaei B., Naraghi M.A., Barbarestani M. Exercise and supraphysiological dose of nandrolone decanoate increase apoptosis in spermatogenic cells. Basic and Clinical Pharmacology and Toxicology 2010, 106:324-330.
25. Silva M., Grillot D., Benito A., Richard C., Nunez G., Fernandez-Luna J.L. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 1996, 88:1576-1582.
26. de Souza G.L., Hallak J. Anabolic steroids and male infertility: a comprehensive review. BJU International 2011, 108:1860-1865.
27. Takahashi M., Tatsugi Y., Kohno T. Endocrinological and pathological effects of anabolic-androgenic steroid in male rats. Endocrine Journal 2004, 51:425-434.
28. Virmani A., Ali S.F., Binienda Z.K. Neuroprotective strategies in drug abuse-evoked. Encephalopathy. Annals of the New York Academy of Sciences 2010, 1199:52-68.
29. Zaugg M., Jamali N.Z., Lucchinetti E., Xu W., Alam M., Shafiq S.A., Siddiqui M.A. Anabolic-androgenic steroids induce apoptotic cell death in adult rat ventricular myocytes. Journal of Cellular Physiology 2001, 187:90-95.